文献速递免疫规划妇幼与学校卫生

美国军队现役女性孕期接种破伤风、白喉和无细胞百日咳疫苗的安全性

Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women.
PubMed 文献 · Vaccine · 2020-01-14

本研究基于美国国防部出生与婴儿健康研究项目数据,纳入2006-2014年145883例现役女性妊娠,评估孕期接种Tdap疫苗的安全性。结果显示,意外暴露(孕0-13周)和推荐暴露(孕27-36周)均未增加自然流产、子痫前期、早产临产及不良婴儿结局风险,与现有文献一致。

要点

  • 孕早期意外接种Tdap疫苗未增加自然流产、子痫前期或早产临产风险。
  • 孕27-36周接种Tdap疫苗未增加任何不良婴儿结局风险。
  • 研究结果支持孕期接种Tdap疫苗的安全性,与现有文献一致。

核心结论

  • 在美国军队现役女性中,孕期接种Tdap疫苗未检测到不良母体、胎儿或婴儿结局风险增加,研究结果与现有文献一致。

研究设计与样本

  • 研究链接美国国防部出生与婴儿健康研究项目数据与军人免疫接种记录,确定2006-2014年现役女性孕期Tdap疫苗暴露,采用多变量Cox回归和广义线性回归模型估计暴露与不良妊娠或婴儿结局的关联。

主要发现

  • 在145883例妊娠中,1272例在孕早期(0-13周)暴露于Tdap疫苗,9438例在孕27-36周暴露;两种暴露均与自然流产、子痫前期或早产临产无关联。
  • 在117724例活产婴儿中,984例在孕早期暴露于Tdap疫苗,9352例在孕27-36周暴露;孕早期暴露与出生缺陷、宫内生长问题、婴儿期生长问题、早产或低出生体重无关联。
  • 孕27-36周暴露于Tdap疫苗与任何不良婴儿结局无关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The tetanus, diphtheria, and acellular pertussis (Tdap) vaccine was approved for U.S. adults in 2005 and recommended for administration in every pregnancy in 2012, with optimal timing between 27 and 36 weeks' gestation. In the military, however, a current Tdap vaccination status is compulsory for service, and active duty women may be inadvertently exposed in early pregnancy. Safety data in this population are limited. OBJECTIVES: To assess safety of inadvertent (0-13 weeks' gestation) and recommended (27-36 weeks' gestation) exposure to the Tdap vaccine in pregnancy. METHODS: Pregnancies and live births from Department of Defense Birth and Infant Health Research program data were linked with military personnel immunization records to determine pregnancy Tdap vaccine exposure among active duty women, 2006-2014. Multivariable Cox and generalized linear regression models estimated associations between Tdap vaccine exposure and adverse pregnancy or infant outcomes. RESULTS: Of 145,883 pregnancies, 1272 were exposed to the Tdap vaccine in the first trimester and 9438 between 27 and 36 weeks' gestation. Neither inadvertent nor recommended vaccine exposure were associated with spontaneous abortion, preeclampsia, or preterm labor. Among 117,724 live born infants, 984 were exposed to the Tdap vaccine in the first trimester and 9352 between 27 and 36 weeks' gestation. First trimester exposure was not associated with birth defects, growth problems in utero, growth problems in infancy, preterm birth, or low birth weight. Tdap vaccine exposure between 27 and 36 weeks' gestation was not associated with any adverse infant outcome. CONCLUSIONS: Among a population of active duty women in the U.S. military who received the Tdap vaccine during pregnancy, we detected no increased risks for adverse maternal, fetal, or infant outcomes. Our findings corroborate existing literature on the safety of exposure to the Tdap vaccine in pregnancy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hall C, Abramovitz LM, Bukowinski AT, et al. Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women. Vaccine. 2020. PMID: 31952872. doi:10.1016/j.vaccine.2020.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。